Erratum: Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis (Neuro-Oncology Advances (2022) 4:1 (vdac075) DOI: 10.1093/noajnl/vdac075)

Mueez Waqar; Federico Roncaroli; Eric J. Lehrer; Joshua D. Palmer; Javier Villanueva-Meyer; Steve Braunstein; Emma Hall; Marianne Aznar; Philip C. De Witt Hamer; Pietro I. D'Urso; Daniel Trifiletti; Alfredo Quiñones-Hinojosa; Pieter Wesseling; Gerben R. Borst

doi:10.1093/noajnl/vdac125

Erratum: Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis (Neuro-Oncology Advances (2022) 4:1 (vdac075) DOI: 10.1093/noajnl/vdac075)

Mueez Waqar
, Federico Roncaroli
, Eric J. Lehrer
, Joshua D. Palmer
, Javier Villanueva-Meyer
, Steve Braunstein
, Emma Hall
, Marianne Aznar
, Philip C. De Witt Hamer
, Pietro I. D'Urso
, Daniel Trifiletti
, Alfredo Quiñones-Hinojosa
, Pieter Wesseling
, Gerben R. Borst

Research related

Onderzoeksoutput: Bijdrage aan tijdschrift › Opmerking/debat

Samenvatting

This is an erratum to: Mueez Waqar, Federico Roncaroli, Eric J Lehrer, Joshua D Palmer, Javier Villanueva-Meyer, Steve Braunstein, Emma Hall, Marianne Aznar, Philip C De Witt Hamer, Pietro I D'Urso, Daniel Trifiletti, Alfredo Quiñones- Hinojosa, Pieter Wesseling, Gerben R Borst, Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis, Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac075, https://doi.org/10.1093/ noajnl/vdac075 In the originally published version of this manuscript, the surname of author Gerben R Borst was inadvertently misspelled as Gerben R Bors. This error has been corrected.

Originele taal-2	Engels
Artikelnummer	vdac125
Tijdschrift	Neuro-Oncology Advances
Volume	4
Nummer van het tijdschrift	1
DOI's	https://doi.org/10.1093/noajnl/vdac125
Status	Gepubliceerd - 1 jan. 2022

Toegang tot document

10.1093/noajnl/vdac125

Vingerafdruk

Duik in de onderzoeksthema's van 'Erratum: Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis (Neuro-Oncology Advances (2022) 4:1 (vdac075) DOI: 10.1093/noajnl/vdac075)'. Samen vormen ze een unieke vingerafdruk.

Citeer dit

Waqar, M., Roncaroli, F., Lehrer, E. J., Palmer, J. D., Villanueva-Meyer, J., Braunstein, S., Hall, E., Aznar, M., De Witt Hamer, P. C., D'Urso, P. I., Trifiletti, D., Quiñones-Hinojosa, A., Wesseling, P., & Borst, G. R. (2022). Erratum: Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis (Neuro-Oncology Advances (2022) 4:1 (vdac075) DOI: 10.1093/noajnl/vdac075). Neuro-Oncology Advances, 4(1), Artikel vdac125. https://doi.org/10.1093/noajnl/vdac125

@article{b1d915ddeebc4c39a0a71b8f18945fde,

title = "Erratum: Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis (Neuro-Oncology Advances (2022) 4:1 (vdac075) DOI: 10.1093/noajnl/vdac075)",

abstract = "This is an erratum to: Mueez Waqar, Federico Roncaroli, Eric J Lehrer, Joshua D Palmer, Javier Villanueva-Meyer, Steve Braunstein, Emma Hall, Marianne Aznar, Philip C De Witt Hamer, Pietro I D'Urso, Daniel Trifiletti, Alfredo Qui{\~n}ones- Hinojosa, Pieter Wesseling, Gerben R Borst, Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis, Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac075, https://doi.org/10.1093/ noajnl/vdac075 In the originally published version of this manuscript, the surname of author Gerben R Borst was inadvertently misspelled as Gerben R Bors. This error has been corrected.",

author = "Mueez Waqar and Federico Roncaroli and Lehrer, \{Eric J.\} and Palmer, \{Joshua D.\} and Javier Villanueva-Meyer and Steve Braunstein and Emma Hall and Marianne Aznar and \{De Witt Hamer\}, \{Philip C.\} and D'Urso, \{Pietro I.\} and Daniel Trifiletti and Alfredo Qui{\~n}ones-Hinojosa and Pieter Wesseling and Borst, \{Gerben R.\}",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s).",

year = "2022",

month = jan,

day = "1",

doi = "10.1093/noajnl/vdac125",

language = "English",

volume = "4",

journal = "Neuro-Oncology Advances",

issn = "2632-2498",

publisher = "Oxford University Press",

number = "1",

}

Waqar, M, Roncaroli, F, Lehrer, EJ, Palmer, JD, Villanueva-Meyer, J, Braunstein, S, Hall, E, Aznar, M, De Witt Hamer, PC, D'Urso, PI, Trifiletti, D, Quiñones-Hinojosa, A, Wesseling, P & Borst, GR 2022, 'Erratum: Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis (Neuro-Oncology Advances (2022) 4:1 (vdac075) DOI: 10.1093/noajnl/vdac075)', Neuro-Oncology Advances, vol. 4, nr. 1, vdac125. https://doi.org/10.1093/noajnl/vdac125

Erratum: Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis (Neuro-Oncology Advances (2022) 4:1 (vdac075) DOI: 10.1093/noajnl/vdac075). / Waqar, Mueez; Roncaroli, Federico; Lehrer, Eric J. et al.
In: Neuro-Oncology Advances, Vol. 4, Nr. 1, vdac125, 01.01.2022.

Onderzoeksoutput: Bijdrage aan tijdschrift › Opmerking/debat

TY - JOUR

T1 - Erratum

T2 - Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis (Neuro-Oncology Advances (2022) 4:1 (vdac075) DOI: 10.1093/noajnl/vdac075)

AU - Waqar, Mueez

AU - Roncaroli, Federico

AU - Lehrer, Eric J.

AU - Palmer, Joshua D.

AU - Villanueva-Meyer, Javier

AU - Braunstein, Steve

AU - Hall, Emma

AU - Aznar, Marianne

AU - De Witt Hamer, Philip C.

AU - D'Urso, Pietro I.

AU - Trifiletti, Daniel

AU - Quiñones-Hinojosa, Alfredo

AU - Wesseling, Pieter

AU - Borst, Gerben R.

PY - 2022/1/1

Y1 - 2022/1/1

N2 - This is an erratum to: Mueez Waqar, Federico Roncaroli, Eric J Lehrer, Joshua D Palmer, Javier Villanueva-Meyer, Steve Braunstein, Emma Hall, Marianne Aznar, Philip C De Witt Hamer, Pietro I D'Urso, Daniel Trifiletti, Alfredo Quiñones- Hinojosa, Pieter Wesseling, Gerben R Borst, Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis, Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac075, https://doi.org/10.1093/ noajnl/vdac075 In the originally published version of this manuscript, the surname of author Gerben R Borst was inadvertently misspelled as Gerben R Bors. This error has been corrected.

AB - This is an erratum to: Mueez Waqar, Federico Roncaroli, Eric J Lehrer, Joshua D Palmer, Javier Villanueva-Meyer, Steve Braunstein, Emma Hall, Marianne Aznar, Philip C De Witt Hamer, Pietro I D'Urso, Daniel Trifiletti, Alfredo Quiñones- Hinojosa, Pieter Wesseling, Gerben R Borst, Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis, Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac075, https://doi.org/10.1093/ noajnl/vdac075 In the originally published version of this manuscript, the surname of author Gerben R Borst was inadvertently misspelled as Gerben R Bors. This error has been corrected.

UR - https://www.scopus.com/pages/publications/85142919833

U2 - 10.1093/noajnl/vdac125

DO - 10.1093/noajnl/vdac125

M3 - Comment/debate

C2 - 35958979

AN - SCOPUS:85142919833

SN - 2632-2498

VL - 4

JO - Neuro-Oncology Advances

JF - Neuro-Oncology Advances

IS - 1

M1 - vdac125

ER -

Waqar M, Roncaroli F, Lehrer EJ, Palmer JD, Villanueva-Meyer J, Braunstein S et al. Erratum: Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis (Neuro-Oncology Advances (2022) 4:1 (vdac075) DOI: 10.1093/noajnl/vdac075). Neuro-Oncology Advances. 2022 jan. 1;4(1):vdac125. doi: 10.1093/noajnl/vdac125